In this article, important concepts in the molecular testing of non–small-cell lung cancer are highlighted.
Kathryn F. Mileham, MD, FACP
Advertisement
Articles by Kathryn F. Mileham, MD, FACP
Advertisement
Latest Updated Articles
Targeted Therapy for Mutation-Driven Metastatic Non–Small-Cell Lung Cancer: Considerations for ALK-Rearranged TumorsPublished: April 15th 2019 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Tr1X's Multiple Sclerosis Cell Therapy TRX319 Cleared for US Trial
2
Krystal Biotech’s Neurotrophic Keratitis Gene Therapy Viral Vector Secures FDA Platform Technology Designation
3
Around the Helix: Cell and Gene Therapy Company Updates – October 15, 2025
4
FDA Picks Abeona’s XLRS Gene Therapy ABO-503 for RDEA Pilot Program
5
